91 related articles for article (PubMed ID: 6717751)
1. Characterisation and distribution of vasoactive intestinal polypeptide binding sites in human brain.
Farmery SM; Owen F; Poulter M; Crow TJ
Neuropharmacology; 1984 Jan; 23(1):101-4. PubMed ID: 6717751
[TBL] [Abstract][Full Text] [Related]
2. Vasoactive intestinal polypeptide: specific binding to rat brain membranes.
Taylor DP; Pert CB
Proc Natl Acad Sci U S A; 1979 Feb; 76(2):660-4. PubMed ID: 218214
[TBL] [Abstract][Full Text] [Related]
3. Autoradiographic mapping of [mono[125I]iodo-Tyr10, MetO17]vasoactive intestinal peptide binding sites in the rat brain.
Martin JL; Dietl MM; Hof PR; Palacios JM; Magistretti PJ
Neuroscience; 1987 Nov; 23(2):539-65. PubMed ID: 3437978
[TBL] [Abstract][Full Text] [Related]
4. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
Zawilska JB; Niewiadomski P; Nowak JZ
Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
[TBL] [Abstract][Full Text] [Related]
5. Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide.
Gottschall PE; Tatsuno I; Miyata A; Arimura A
Endocrinology; 1990 Jul; 127(1):272-7. PubMed ID: 2361473
[TBL] [Abstract][Full Text] [Related]
6. Autoradiographic analysis of the distribution of vasoactive intestinal peptide binding sites in the vertebrate central nervous system: a phylogenetic study.
Dietl MM; Hof PR; Martin JL; Magistretti PJ; Palacios JM
Brain Res; 1990 Jun; 520(1-2):14-26. PubMed ID: 2169952
[TBL] [Abstract][Full Text] [Related]
7. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas.
Le Meuth V; Farjaudon N; Bawab W; Chastre E; Rosselin G; Guilloteau P; Gespach C
Am J Physiol; 1991 Feb; 260(2 Pt 1):G265-74. PubMed ID: 1847591
[TBL] [Abstract][Full Text] [Related]
8. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide receptors in chick cerebral cortex.
Zawilska JB; Niewiadomski P; Nowak JZ
J Mol Neurosci; 2003 Apr; 20(2):153-62. PubMed ID: 12794309
[TBL] [Abstract][Full Text] [Related]
9. Binding sites of a novel neuropeptide pituitary-adenylate-cyclase-activating polypeptide in the rat brain and lung.
Lam HC; Takahashi K; Ghatei MA; Kanse SM; Polak JM; Bloom SR
Eur J Biochem; 1990 Nov; 193(3):725-9. PubMed ID: 2249690
[TBL] [Abstract][Full Text] [Related]
10. Distribution of vasoactive intestinal polypeptide (VIP) binding in circular muscle and characterization of VIP binding in canine small intestinal mucosa.
Mao YK; Barnett W; Coy DH; Tougas G; Daniel EE
J Pharmacol Exp Ther; 1991 Sep; 258(3):986-91. PubMed ID: 1653848
[TBL] [Abstract][Full Text] [Related]
11. VIP receptor subtypes in mouse cerebral cortex: evidence for a differential localization in astrocytes, microvessels and synaptosomal membranes.
Martin JL; Feinstein DL; Yu N; Sorg O; Rossier C; Magistretti PJ
Brain Res; 1992 Jul; 587(1):1-12. PubMed ID: 1326373
[TBL] [Abstract][Full Text] [Related]
12. Secretin: specific binding to rat brain membranes.
Fremeau RT; Jensen RT; Charlton CG; Miller RL; O'Donohue TL; Moody TW
J Neurosci; 1983 Aug; 3(8):1620-5. PubMed ID: 6308185
[TBL] [Abstract][Full Text] [Related]
13. Characterization of vasoactive intestinal peptide receptors in canine liver membranes.
Kiso T; Ito S; Ohta T; Asano T; Nakazato Y
Biochem Pharmacol; 1994 Jan; 47(2):241-5. PubMed ID: 8304967
[TBL] [Abstract][Full Text] [Related]
14. Binding sites for pituitary adenylate cyclase activating polypeptide (PACAP): comparison with vasoactive intestinal polypeptide (VIP) binding site localization in rat brain sections.
Masuo Y; Ohtaki T; Masuda Y; Tsuda M; Fujino M
Brain Res; 1992 Mar; 575(1):113-23. PubMed ID: 1324082
[TBL] [Abstract][Full Text] [Related]
15. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
Zawilska JB; Dejda A; Niewiadomski P; Gozes I; Nowak JZ
J Mol Neurosci; 2005; 25(3):215-24. PubMed ID: 15800375
[TBL] [Abstract][Full Text] [Related]
16. Characterization and autoradiographic distribution of vasoactive intestinal peptide binding sites in the rat central nervous system.
Besson J; Sarrieau A; Vial M; Marie JC; Rosselin G; Rostene W
Brain Res; 1986 Nov; 398(2):329-36. PubMed ID: 3801907
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of mitogen-stimulated proliferation of murine splenocytes by a novel neuropeptide, pituitary adenylate cyclase activating polypeptide: a comparative study with vasoactive intestinal peptide.
Tatsuno I; Gottschall PE; Arimura A
Endocrinology; 1991 Feb; 128(2):728-34. PubMed ID: 1989859
[TBL] [Abstract][Full Text] [Related]
18. Characterization of vasoactive intestinal peptide receptors in human liver.
RodrÃguez-Henche N; RodrÃguez-Pena MS; Guijarro LG; Prieto JC
Biochim Biophys Acta; 1994 Mar; 1221(2):193-8. PubMed ID: 8148398
[TBL] [Abstract][Full Text] [Related]
19. Localisation and characterisation of functional vasoactive intestinal peptide receptors in feline kidney.
Griffiths NM; Simmons NL
Pflugers Arch; 1990 Apr; 416(1-2):80-7. PubMed ID: 2162036
[TBL] [Abstract][Full Text] [Related]
20. Molecular identification and structural requirement of vasoactive intestinal peptide (VIP) receptors in the human colon adenocarcinoma cell line, HT-29.
Couvineau A; Rousset M; Laburthe M
Biochem J; 1985 Oct; 231(1):139-43. PubMed ID: 2998337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
